Skip to main content
Erschienen in: European Radiology 5/2012

01.05.2012 | Interventional

Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (>7 cm) tumours

verfasst von: Federico Collettini, Dirk Schnapauff, Alexander Poellinger, Timm Denecke, Eckart Schott, Thomas Berg, Peter Wust, Bernd Hamm, Bernhard Gebauer

Erschienen in: European Radiology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Objectives

Evaluate the clinical outcome of CT-guided high-dose-rate-brachytherapy (CT-HDRBT) of hepatocellular carcinoma (HCC) larger than 5 cm in diameter with the goal of local tumour control (LTC).

Methods

Thirty-five patients with 35 unresectable HCCs ranging in size from 5 to 12 cm (mean: 7.1 cm) were treated with CT-HDRBT. Tumours were classified into two groups according to diameter: “large lesions” (5–7 cm) and “very large lesions” (>7 cm). Tumour response was evaluated by Gd-EOB-DTPA-enhanced liver magnetic resonance imaging (MRI) performed before, 6 weeks after, and then every 3 months after treatment. Endpoints included local tumour control (LTC), progression-free survival (PFS) and overall survival (OS).

Results

Nineteen tumours were classified as “large” and 16 as “very large”. Complete tumour enclosure was achieved in all patients after the first CT-HDRBT session. Five patients were lost to follow-up. At a mean follow-up of 12.8 months, two patients had local progression (6.7%), one in each group. Nine patients (30%) experienced distant progression, five (26.3%) in the “large” and four (25%) in the “very large” group. No patients died during the follow-up period. No major complications were recorded.

Conclusions

CT-HDRBT is a promising therapy for HCCs that exceed indications for thermal ablation.

Key Points

Computed Tomography guided high-dose-rate brachytherapy offers new therapeutic options for hepatocellular carcinoma
CT-HDRBT can be safely practised in HCCs exceeding 5 cm in diameter
CT-HDRBT offers high rate of local control where thermal ablation is impossible
CT-HDRBT could be a valid alternative to TACE for intermediate stage HCC
Literatur
1.
Zurück zum Zitat Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614–6PubMedCrossRef Bruix J, Llovet JM (2009) Major achievements in hepatocellular carcinoma. Lancet 373(9664):614–6PubMedCrossRef
2.
Zurück zum Zitat Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–73PubMedCrossRef Lencioni R (2010) Loco-regional treatment of hepatocellular carcinoma. Hepatology 52:762–73PubMedCrossRef
3.
Zurück zum Zitat Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation. Cancer 88:2452–2463PubMedCrossRef Goldberg SN, Gazelle GS, Compton CC, Mueller PR, Tanabe KK (2000) Treatment of intrahepatic malignancy with radiofrequency ablation. Cancer 88:2452–2463PubMedCrossRef
4.
Zurück zum Zitat Goldberg SN (2002) Comparison of techniques for image-guided ablation of focal liver tumors. Radiology 223:304–307PubMedCrossRef Goldberg SN (2002) Comparison of techniques for image-guided ablation of focal liver tumors. Radiology 223:304–307PubMedCrossRef
5.
Zurück zum Zitat Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–7PubMedCrossRef Lencioni R, Cioni D, Crocetti L, Franchini C, Pina CD, Lera J et al (2005) Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234:961–7PubMedCrossRef
6.
Zurück zum Zitat Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M et al (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 8:1121–1126 Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M et al (1993) Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 8:1121–1126
7.
Zurück zum Zitat Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B et al (2002) Percutaneous ethanol injection vs resection in patients with small single hepatocellular carcinoma: a retrospective case–control study with cost analysis. Aliment Pharmacol Ther 16:1529–1538PubMedCrossRef Gournay J, Tchuenbou J, Richou C, Masliah C, Lerat F, Dupas B et al (2002) Percutaneous ethanol injection vs resection in patients with small single hepatocellular carcinoma: a retrospective case–control study with cost analysis. Aliment Pharmacol Ther 16:1529–1538PubMedCrossRef
8.
Zurück zum Zitat Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–8PubMedCrossRef Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–8PubMedCrossRef
9.
Zurück zum Zitat Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–505PubMedCrossRef Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–505PubMedCrossRef
10.
Zurück zum Zitat Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R et al (2010) Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 78:172–9PubMedCrossRef Mohnike K, Wieners G, Schwartz F, Seidensticker M, Pech M, Ruehl R et al (2010) Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival. Int J Radiat Oncol Biol Phys 78:172–9PubMedCrossRef
11.
Zurück zum Zitat Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 180:274–80PubMedCrossRef Ricke J, Wust P, Stohlmann A, Beck A, Cho CH, Pech M et al (2004) CT-Guided brachytherapy. A novel percutaneous technique for interstitial ablation of liver metastases. Strahlenther Onkol 180:274–80PubMedCrossRef
12.
Zurück zum Zitat Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216PubMedCrossRef Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216PubMedCrossRef
13.
Zurück zum Zitat Ricke J, Thormann M, Ludewig M, Jungnickel K, Grosser O, Wybranski C et al (2010) MR-guided liver tumor ablation employing open high-field 1.0 T MRI for image-guided brachytherapy. Eur Radiol 20:1985–93PubMedCrossRef Ricke J, Thormann M, Ludewig M, Jungnickel K, Grosser O, Wybranski C et al (2010) MR-guided liver tumor ablation employing open high-field 1.0 T MRI for image-guided brachytherapy. Eur Radiol 20:1985–93PubMedCrossRef
14.
Zurück zum Zitat Goldberg SN, Grassi CJ, Cardella JF, for the Society of Interventional Radiology et al (2009) Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–90PubMedCrossRef Goldberg SN, Grassi CJ, Cardella JF, for the Society of Interventional Radiology et al (2009) Technology Assessment Committee and the International Working Group on Image-guided Tumor Ablation. Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–90PubMedCrossRef
15.
Zurück zum Zitat Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–9PubMedCrossRef Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–9PubMedCrossRef
16.
Zurück zum Zitat Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43PubMedCrossRef Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35–43PubMedCrossRef
17.
Zurück zum Zitat Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–9PubMedCrossRef Ayav A, Germain A, Marchal F, Tierris I, Laurent V, Bazin C et al (2010) Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence. Am J Surg 200:435–9PubMedCrossRef
18.
Zurück zum Zitat Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z et al (2011) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in childs A Cirrhotics-a retrospective study of 1,061 Cases. J Gastrointest Surg 15:311–20PubMedCrossRef Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z et al (2011) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in childs A Cirrhotics-a retrospective study of 1,061 Cases. J Gastrointest Surg 15:311–20PubMedCrossRef
19.
Zurück zum Zitat Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115:1914–23PubMedCrossRef Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M et al (2009) Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer 115:1914–23PubMedCrossRef
20.
Zurück zum Zitat Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33:11–7PubMedCrossRef Crocetti L, de Baere T, Lencioni R (2010) Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol 33:11–7PubMedCrossRef
21.
Zurück zum Zitat Yang WZ, Jiang N, Huang N, Huang JY, Zheng QB, Shen Q (2009) Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol 15:748–52PubMedCrossRef Yang WZ, Jiang N, Huang N, Huang JY, Zheng QB, Shen Q (2009) Combined therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation for small hepatocellular carcinoma. World J Gastroenterol 15:748–52PubMedCrossRef
22.
Zurück zum Zitat Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661–9PubMedCrossRef Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661–9PubMedCrossRef
23.
Zurück zum Zitat Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–27PubMedCrossRef Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–27PubMedCrossRef
24.
Zurück zum Zitat Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–90PubMedCrossRef Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–90PubMedCrossRef
25.
Zurück zum Zitat Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34PubMedCrossRef Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS et al (2009) Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25–34PubMedCrossRef
26.
Zurück zum Zitat Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–9PubMedCrossRef Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734–9PubMedCrossRef
27.
Zurück zum Zitat Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–7PubMedCrossRef Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–7PubMedCrossRef
28.
Zurück zum Zitat Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52PubMedCrossRef Lammer J, Malagari K, Vogl T, Pilleul F, Denys A, Watkinson A et al (2010) Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol 33:41–52PubMedCrossRef
29.
Zurück zum Zitat Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF et al (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49:1185–1193PubMedCrossRef Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF et al (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49:1185–1193PubMedCrossRef
30.
Zurück zum Zitat Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230PubMedCrossRef Kooby DA, Egnatashvili V, Srinivasan S, Chamsuddin A, Delman KA, Kauh J et al (2010) Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol 21:224–230PubMedCrossRef
31.
Zurück zum Zitat Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S et al (2011) Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across barcelona clinic liver cancer stages: A European evaluation. Hepatology 26. doi:10.1002/hep.24451 Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S et al (2011) Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across barcelona clinic liver cancer stages: A European evaluation. Hepatology 26. doi:10.​1002/​hep.​24451
32.
Zurück zum Zitat Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G et al (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol 31:1141–9PubMedCrossRef Grosso M, Vignali C, Quaretti P, Nicolini A, Melchiorre F, Gallarato G et al (2008) Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheres: preliminary results from an Italian multicentre study. Cardiovasc Intervent Radiol 31:1141–9PubMedCrossRef
33.
Zurück zum Zitat Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y et al (2008) Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res 38:60–69PubMedCrossRef Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y et al (2008) Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity. Hepatol Res 38:60–69PubMedCrossRef
34.
Zurück zum Zitat Louis C (2010) Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. Technol Cancer Res Treat 9(5):479–87PubMed Louis C (2010) Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results. Technol Cancer Res Treat 9(5):479–87PubMed
35.
Zurück zum Zitat Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH et al (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102:209–14PubMedCrossRef Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH et al (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102:209–14PubMedCrossRef
36.
Zurück zum Zitat Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664PubMedCrossRef Tse RV, Hawkins M, Lockwood G, Kim JJ, Cummings B, Knox J et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664PubMedCrossRef
37.
Zurück zum Zitat Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 127:1714–1723PubMedCrossRef Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC (2004) Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma <4 cm. Gastroenterology 127:1714–1723PubMedCrossRef
38.
Zurück zum Zitat Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T et al (2010) Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:541–51PubMedCrossRef Malagari K, Pomoni M, Kelekis A, Pomoni A, Dourakis S, Spyridopoulos T et al (2010) Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma. Cardiovasc Intervent Radiol 33:541–51PubMedCrossRef
39.
Zurück zum Zitat Wieners G, Pech M, Wust P, Miersch A, Streitparth F, Berg T et al (2005) CT-gestützte Brachytherapie bei hepatozellulärem Karzinom (HCC): Ergebnisse einer prospektiven Phase-II-Studie. Fortschr Röntgenstr doi:. doi:10.1055/s-2005-867648 Wieners G, Pech M, Wust P, Miersch A, Streitparth F, Berg T et al (2005) CT-gestützte Brachytherapie bei hepatozellulärem Karzinom (HCC): Ergebnisse einer prospektiven Phase-II-Studie. Fortschr Röntgenstr doi:. doi:10.​1055/​s-2005-867648
40.
Zurück zum Zitat Mohnike K, Wieners G, Pech M, Seidensticker M, Rühl R, Lopez-Haenninen E et al (2009) Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma. Dig Dis 27:170–4PubMedCrossRef Mohnike K, Wieners G, Pech M, Seidensticker M, Rühl R, Lopez-Haenninen E et al (2009) Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma. Dig Dis 27:170–4PubMedCrossRef
Metadaten
Titel
Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5–7 cm) and very large (>7 cm) tumours
verfasst von
Federico Collettini
Dirk Schnapauff
Alexander Poellinger
Timm Denecke
Eckart Schott
Thomas Berg
Peter Wust
Bernd Hamm
Bernhard Gebauer
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
European Radiology / Ausgabe 5/2012
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2352-7

Weitere Artikel der Ausgabe 5/2012

European Radiology 5/2012 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.